Formulations containing an ionic mineral-ion exchange resin complex and uses thereof
View Patent ↗A process for preparing a formulation comprising a complex comprising an effective amount of ferrous iron bound to a pharmaceutically acceptable cationic resin and at least one pharmaceutically acceptable carrier is described. Such a formulation may optionally include other desirable dietary supplements including, e.g., vitamins, omega fatty acids, and/or fluoride. The formulation is particularly well adapted for pediatric use, but is also useful for use in adult populations.
1. A process for preparing an orally ingestible aqueous iron suspension in situ comprising:
combining a pharmaceutically acceptable cation exchange resin with an aqueous solution comprising an antioxidant and a ferrous iron to form an aqueous suspension;
stirring the aqueous suspension for a sufficient amount of time to permit formation of a ferrous-ion exchange resin complex comprising about 25% to about 70% by weight ferrous iron based on the weight of the ferrous-ion exchange resin complex;
optionally combining one or more additional active components with said aqueous suspension prior to completion of complex formation; and
mixing said aqueous suspension comprising the ferrous-ion exchange resin complex with one or more active or inactive components to form the orally ingestible ferrous aqueous suspension, wherein the process is performed in a single container without the need for isolation or drying of the mineral-ion exchange resin complex prior to forming the orally ingestible liquid suspension.
2. The process according to claim 1 , wherein the antioxidant is present in an amount of about 2.5% w/v to about 10% w/v.
3. The process according to claim 1 , wherein ferrous iron combined into the aqueous solution is added in the form of ferrous sulfate or a hydrate thereof.
4. The process according to claim 1 , wherein the ferrous iron is ferrous sulfate heptahydrate.
5. The process according to claim 1 , wherein the antioxidant is selected from one or more of ascorbic acid and pharmaceutically acceptable salts thereof, butylated hydroxyanisole, butylated hydroxytoluene, sodium metabisulfite, and sodium bisulfate.
6. The process according to claim 1 , wherein the orally ingestible ferrous aqueous suspension comprises the ferrous-ion exchange resin complex and butylated hydroxyanisole.
7. The process according to claim 6 , wherein the orally ingestible ferrous aqueous suspension further comprises Vitamin C.
8. The process according to claim 6 , wherein the orally ingestible ferrous aqueous suspension further comprises Vitamin A and Vitamin D.
9. The process according to claim 6 , wherein the orally ingestible ferrous aqueous suspension further comprises fluoride.
10. The process according to claim 1 , wherein the antioxidant is present in an amount of about 0.05 to about 2% w/v.
11. The process according to claim 1 , wherein the ferrous iron component is mixed with the ion exchange resin in an amount to allow loading of about 25 to about 40% by weight, of the ferrous iron onto the ion exchange resin.
12. The process according to claim 1 , wherein the cation exchange resin has an average particle size of about 5 microns to about 150 microns.
13. The process according to claim 1 , wherein the iron is a ferrous sulfate and the orally ingestible aqueous iron suspension comprising the iron-cation exchange complex further contains ferrous sulfate.
14. The process according to claim 1 , wherein the complex is in an amount of about 5 to about 50% w/v in the aqueous suspension.
15. The process according to claim 1 , wherein the complex is in an amount of about 10 to about 25% w/v in the aqueous suspension.
16. The process according to claim 1 , wherein the ferrous iron is provided from a salt or complex selected from the group consisting of ferrous sulfate, ferrous fumarate, ferrous polymaltose, ferrous bisglycinate, ferrous glycine sulphate, ferrous gluconate, ferrous citrate, ferrous carbonate, ferrous lactate, ferrous succinate, ferrous ascorbate, an amino acid ferrous complex, or a hydrate thereof.
17. The process according to claim 1 , wherein ferrous iron is added into a solution in the form of a salt or complex, which salt or complex is dissolved in an aqueous solution prior to reacting with the ion exchange resin complex.
18. The process according to claim 1 , wherein the liquid suspension further comprises an omega-3-fatty acid component and/or folate.
19. The process according to claim 1 , wherein an antioxidant and/or a fluoride compound are added prior to the reaction between the at least one ionic mineral and the ion exchange resin.
20. The process according to claim 1 , wherein one or more vitamins or minerals are added after forming the ferrous iron-ion exchange resin complex.
21. The process according to claim 19 , wherein the fluoride compound or complex is selected from the group consisting of sodium fluoride, sodium monofluorophosphate, and stannous fluoride.
22. The process according to claim 20 , wherein the vitamin is selected from the group consisting of one or more of Vitamin A, Vitamin C and Vitamin D.
23. The process according to claim 20 , wherein the one or more vitamins or nutrients is selected from the group consisting of one or more of Vitamin A, niacin, nicotinic aid, folate, folic acid, Vitamin C, Vitamin D, Vitamin K, Vitamin E, and the Vitamin B family, and fluoride.
24. A process for preparing an orally ingestible aqueous liquid iron suspension in a single vessel comprising:
mixing an aqueous suspension in a single vessel, said aqueous suspension comprising a pharmaceutically acceptable cation exchange resin, an antioxidant, water and a ferrous iron for a sufficient amount of time to permit formation of a ferrous-cation exchange resin complex comprising about 25% to about 70% by weight ferrous iron based on the weight of the ferrous-ion exchange resin complex;
adding one or more active or inactive components into the single vessel containing the aqueous liquid suspension to form the orally ingestible iron aqueous suspension, wherein the process is performed without isolation or drying of the iron-cation exchange resin complex prior to forming the orally ingestible liquid suspension.